These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 11780473

  • 41. Transarterial radioembolization with Yttrium-90 for regional management of hepatocellular cancer: the early results of a nontransplant center.
    Holt A, Wagman LD, Senthil M, McKenzie S, Marx H, Chen YJ, Vora N, Kim J.
    Am Surg; 2010 Oct; 76(10):1079-83. PubMed ID: 21105614
    [Abstract] [Full Text] [Related]

  • 42. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
    Salem R, Thurston KG.
    J Vasc Interv Radiol; 2006 Aug; 17(8):1251-78. PubMed ID: 16923973
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Thrombocytopenia following 90Yttrium glass microsphere liver radioembolization.
    Gundavaram P, Gaba RC.
    South Med J; 2011 Apr; 104(4):286. PubMed ID: 21606701
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Hickey RM, Lewandowski RJ, Salem R.
    Semin Nucl Med; 2016 Mar; 46(2):105-8. PubMed ID: 26897714
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review.
    Kallini JR, Gabr A, Thorlund K, Balijepalli C, Ayres D, Kanters S, Ebrahim S, Mills E, Lewandowski RJ, Salem R.
    Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1033-1043. PubMed ID: 28246879
    [Abstract] [Full Text] [Related]

  • 60. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
    Powerski MJ, Scheurig-Münkler C, Banzer J, Schnapauff D, Hamm B, Gebauer B.
    Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.